Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary:
- To assess the overall response rate of oxaliplatin in patients with bidimensionally
measurable disease at baseline.
Secondary:
- To assess the safety and tolerability of oxaliplatin
- To assess time to progression and overall survival.